These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

787 related articles for article (PubMed ID: 29896673)

  • 1. KSHV Genome Replication and Maintenance in Latency.
    Ueda K
    Adv Exp Med Biol; 2018; 1045():299-320. PubMed ID: 29896673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
    Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of Kaposi's Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene.
    Tso FY; West JT; Wood C
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12).
    Muralidhar S; Veytsmann G; Chandran B; Ablashi D; Doniger J; Rosenthal LJ
    J Clin Virol; 2000 May; 16(3):203-13. PubMed ID: 10738139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin.
    Lu J; Jha HC; Verma SC; Sun Z; Banerjee S; Dzeng R; Robertson ES
    J Virol; 2014 Apr; 88(8):4204-17. PubMed ID: 24478433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
    Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
    mBio; 2018 May; 9(3):. PubMed ID: 29739902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells.
    Hu J; Garber AC; Renne R
    J Virol; 2002 Nov; 76(22):11677-87. PubMed ID: 12388727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research].
    Watanabe T; Fujimuro M
    Yakugaku Zasshi; 2019; 139(1):69-73. PubMed ID: 30606932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology and Molecular Biology.
    Li S; Bai L; Dong J; Sun R; Lan K
    Adv Exp Med Biol; 2017; 1018():91-127. PubMed ID: 29052134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latency.
    Mariggiò G; Koch S; Zhang G; Weidner-Glunde M; Rückert J; Kati S; Santag S; Schulz TF
    PLoS Pathog; 2017 Apr; 13(4):e1006335. PubMed ID: 28430817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic Landscape of Kaposi's Sarcoma-Associated Herpesvirus Genome in Classic Kaposi's Sarcoma Tissues.
    Sun R; Tan X; Wang X; Wang X; Yang L; Robertson ES; Lan K
    PLoS Pathog; 2017 Jan; 13(1):e1006167. PubMed ID: 28118409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ubiquitin-specific protease USP7 modulates the replication of Kaposi's sarcoma-associated herpesvirus latent episomal DNA.
    Jäger W; Santag S; Weidner-Glunde M; Gellermann E; Kati S; Pietrek M; Viejo-Borbolla A; Schulz TF
    J Virol; 2012 Jun; 86(12):6745-57. PubMed ID: 22514345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral latent proteins as targets for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) induced lymphoma.
    Staudt MR; Dittmer DP
    Curr Drug Targets Infect Disord; 2003 Jun; 3(2):129-35. PubMed ID: 12769790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Expression and Nuclear Retention Element of Polyadenylated Nuclear RNA Is Not Required for Productive Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.
    Gutierrez IV; Dayton J; Harger S; Rossetto CC
    J Virol; 2021 Jun; 95(13):e0009621. PubMed ID: 33853955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.
    Sarek G; Järviluoma A; Moore HM; Tojkander S; Vartia S; Biberfeld P; Laiho M; Ojala PM
    PLoS Pathog; 2010 Mar; 6(3):e1000818. PubMed ID: 20333249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection.
    Katano H
    Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection.
    Lu J; Verma SC; Cai Q; Robertson ES
    J Virol; 2011 Jul; 85(13):6148-61. PubMed ID: 21507979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular pathology of Kaposi's sarcoma-associated herpesvirus.
    Jenner RG; Boshoff C
    Biochim Biophys Acta; 2002 Mar; 1602(1):1-22. PubMed ID: 11960692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of LANA at nuclear matrix fraction is important for Kaposi's sarcoma-associated herpesvirus replication in latency.
    Ohsaki E; Suzuki T; Karayama M; Ueda K
    Virus Res; 2009 Jan; 139(1):74-84. PubMed ID: 19027806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.